Early nephrotic syndrome after vaccination for SARS-CoV-2 with Pfizer – BioNTech in a patient with bisalbuminemia

Authors

Keywords:

Nephrotic syndrome, Pfizer-BioNTech, COVID-19 vaccine, bisalbuminemia, adverse effect

Abstract

Background: Nephrotic syndrome (NS) is a clinical syndrome defined by massive proteinuria greater than 3.5 g/24h, responsible for hypoalbuminemia (less than 30 g/L), with resulting hyperlipidemia, edema, and various complications. It is caused by increased permeability through the damaged basement membrane in the renal glomerulus. Etiologies include primary and secondary causes, among which are systemic, metabolic, genetic, infectious, neoplastic, and pharmacological diseases. Among the complications to be considered, the state of hypercoagulability, susceptibility to infections, and an increase in cardiovascular risk should be highlighted.

Downloads

Download data is not yet available.

Published

2023-06-20

How to Cite

Dulce, J. A. ., Aroca Martínez, G., Mercado Marchena, R. ., Mantilla Morales, Y. ., Herrera Martínez, D. ., & García Tolosa, R. . (2023). Early nephrotic syndrome after vaccination for SARS-CoV-2 with Pfizer – BioNTech in a patient with bisalbuminemia. Gaceta Médica De Caracas, 131(2). Retrieved from https://saber.ucv.ve/ojs/index.php/rev_gmc/article/view/26694

Issue

Section

CASOS CLÍNICOS

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.